AAAAAA

   
Results: 1-3 |
Results: 3
A BRIEF PAPER OF THE EFFICACY AND SAFETY OF ATORVASTATIN IN EARLY CLINICAL-TRIALS
Authors: BAKKERARKEMA RG BEST J FAYYAD R HEINONEN TM MARAIS AD NAWROCKI JW BLACK DM
Citation: Rg. Bakkerarkema et al., A BRIEF PAPER OF THE EFFICACY AND SAFETY OF ATORVASTATIN IN EARLY CLINICAL-TRIALS, Perfusion, 11(2), 1998, pp. 79-86
A BRIEF REVIEW PAPER OF THE EFFICACY AND SAFETY OF ATORVASTATIN IN EARLY CLINICAL-TRIALS
Authors: BAKKERARKEMA RG BEST J FAYYAD R HEINONEN TM MARAIS AD NAWROCKI JW BLACK DM
Citation: Rg. Bakkerarkema et al., A BRIEF REVIEW PAPER OF THE EFFICACY AND SAFETY OF ATORVASTATIN IN EARLY CLINICAL-TRIALS, Atherosclerosis, 131(1), 1997, pp. 17-23
THE LIPID-LOWERING EFFECTS OF ATORVASTATIN, A NEW HMG-COA REDUCTASE INHIBITOR - RESULTS OF A RANDOMIZED, DOUBLE-MASKED STUDY
Authors: HEINONEN TM STEIN E WEISS SR MCKENNEY JM DAVIDSON M SHURZINSKE L BLACK DM
Citation: Tm. Heinonen et al., THE LIPID-LOWERING EFFECTS OF ATORVASTATIN, A NEW HMG-COA REDUCTASE INHIBITOR - RESULTS OF A RANDOMIZED, DOUBLE-MASKED STUDY, Clinical therapeutics, 18(5), 1996, pp. 853-863
Risultati: 1-3 |